245 related articles for article (PubMed ID: 3922829)
21. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
Hashimoto H; Satoh N; Takiguchi Y; Nakashima M
J Pharmacol Exp Ther; 1990 May; 253(2):552-7. PubMed ID: 2159998
[TBL] [Abstract][Full Text] [Related]
22. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
23. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.
Matsumoto T; Ono Y; Kurono M; Kuromiya A; Nakamura K; Bril V
J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat.
Ao S; Shingu Y; Kikuchi C; Takano Y; Nomura K; Fujiwara T; Ohkubo Y; Notsu Y; Yamaguchi I
Metabolism; 1991 Jan; 40(1):77-87. PubMed ID: 1898618
[TBL] [Abstract][Full Text] [Related]
25. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
[TBL] [Abstract][Full Text] [Related]
26. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
Takiguchi Y; Wada K; Nakashima M
Eur J Pharmacol; 1992 May; 215(2-3):289-91. PubMed ID: 1396993
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats.
Matsui T; Nakamura Y; Ishikawa H; Matsuura A; Kobayashi F
Jpn J Pharmacol; 1994 Feb; 64(2):115-24. PubMed ID: 8028228
[TBL] [Abstract][Full Text] [Related]
28. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
29. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
30. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
[TBL] [Abstract][Full Text] [Related]
31. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
[TBL] [Abstract][Full Text] [Related]
32. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
[TBL] [Abstract][Full Text] [Related]
33. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
34. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
35. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.
Yagihashi S; Yamagishi SI; Wada Ri R; Baba M; Hohman TC; Yabe-Nishimura C; Kokai Y
Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599
[TBL] [Abstract][Full Text] [Related]
36. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
[TBL] [Abstract][Full Text] [Related]
37. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
Naeser P; Brolin SE; Eriksson UJ
Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
[TBL] [Abstract][Full Text] [Related]
38. Effects of aldose reductase inhibitor on the peripheral nerve function during ischemia in diabetics.
Kuriya N; Miyake S; Yokota A; Yamaguchi Y; Nakanishi T; Takahashi A; Ueda Y; Mori T; Akiguchi I; Toyama K
J Med Assoc Thai; 1987 Mar; 70 Suppl 2():168-72. PubMed ID: 3110345
[No Abstract] [Full Text] [Related]
39. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
Cotter MA; Cameron NE; Hohman TC
J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
[TBL] [Abstract][Full Text] [Related]
40. Studies on WF-3681, a novel aldose reductase inhibitor. IV. Effect of FR-62765, a derivative of WF-3681, on the diabetic neuropathy in rats.
Nishikawa M; Yoshida K; Okamoto M; Itoh Y; Kohsaka M
J Antibiot (Tokyo); 1991 Apr; 44(4):441-4. PubMed ID: 1903376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]